Tapinarof Cream Under FDA Review for Atopic Dermatitis Indication | MDedge Dermatology

preview_player
Показать описание
Dermavant Sciences announced the company's submission of supplemental New Drug Application (sNDA) to the Food and Drug Administration for tapinarof cream, 1%, for treating atopic dermatitis (AD) in adults and children 2 years of age and older.
Рекомендации по теме